Hagens berman, national trial attorneys, alerts ginkgo bioworks (dna) investors to contact firm's attorneys now, firm investigating possible securities law violations

San francisco, oct. 7, 2021 /prnewswire/ -- hagens berman urges ginkgo bioworks holdings, inc. (nyse: dna) investors with significant losses to submit your losses now.  visit: www.hbsslaw.com/investor-fraud/dna contact an attorney now: dna@hbsslaw.com                                               844-916-0895 ginkgo bioworks holdings, inc. (dna) investigation: ginkgo bioworks is a synthetic biology company that uses a cell programming platform called "ginkgo foundry" to assist companies in finding more effective ways to create products.
DNA Ratings Summary
DNA Quant Ranking